Get the Stockscreener App
1.79
16.99%
0.26
After Hours:
1.83
0.04
+2.23%
Humacyte Inc stock is traded at $1.79, with a volume of 9.15M.
It is up +16.99% in the last 24 hours and down -0.56% over the past month.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
See More
Previous Close:
$1.53
Open:
$1.57
24h Volume:
9.15M
Relative Volume:
2.26
Market Cap:
$283.49M
Revenue:
-
Net Income/Loss:
$-110.78M
P/E Ratio:
-1.6729
EPS:
-1.07
Net Cash Flow:
$-75.59M
1W Performance:
+19.33%
1M Performance:
-0.56%
6M Performance:
-42.81%
1Y Performance:
-66.48%
1-Day Range:
$1.57
$1.88
1-Week Range:
$1.45
$1.88
52-Week Range:
$1.15
$6.77
Humacyte Inc Stock (HUMA) Company Profile
Name
Humacyte Inc
Sector
Industry
Phone
919-313-9633
Address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Compare HUMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
1.79 | 243.02M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.11 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.71 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.17 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
731.77 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.89 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-25 | Initiated | Barclays | Overweight |
| May-14-25 | Resumed | H.C. Wainwright | Buy |
| Dec-20-24 | Reiterated | H.C. Wainwright | Buy |
| Dec-11-23 | Initiated | H.C. Wainwright | Buy |
| Aug-14-23 | Upgrade | Piper Sandler | Underweight → Neutral |
| Jun-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-16-22 | Downgrade | Piper Sandler | Overweight → Underweight |
| Oct-29-21 | Initiated | Cowen | Outperform |
| Sep-24-21 | Initiated | Oppenheimer | Outperform |
| Sep-22-21 | Initiated | BTIG Research | Buy |
| Sep-16-21 | Initiated | Piper Sandler | Overweight |
View All
Humacyte Inc Stock (HUMA) Latest News
Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback - Benzinga
Humacyte’s engineered vessel shows promise in coronary bypass study - Investing.com India
Aug Selloffs: How much upside does Humacyte Inc. haveMarket Activity Report & Expert Verified Movement Alerts - خودرو بانک
Humacyte Announces Publication of Preclinical Data on Use of the CTEV as a Coronary Artery Bypass Graft (CABG) - The Manila Times
Breakthrough in Heart Surgery: Humacyte's Bioengineered Vessel Maintains Perfect Blood Flow for 6 Months - Stock Titan
Humacyte Amends Revenue Agreement with TPC Investments - TipRanks
Woodline Partners LP Raises Holdings in Humacyte, Inc. $HUMA - MarketBeat
Humacyte’s Big Bet On Next-Gen Vascular Grafts Faces Huge Hurdles - Finimize
Aug Final Week: Will Humacyte Inc Equity Warrant outperform its industry peersJuly 2025 Levels & Real-Time Market Sentiment Alerts - خودرو بانک
Recap Report: What is the dividend yield of VIVK2025 Earnings Impact & Fast Gain Stock Tips - خودرو بانک
Aug Outlook: Will Humacyte Inc Equity Warrant outperform its industry peersTrade Entry Report & Safe Entry Momentum Stock Tips - خودرو بانک
Earnings Beat: Can Humacyte Inc. scale operations efficientlyPortfolio Gains Report & Real-Time Market Trend Scan - خودرو بانک
Institution Moves: Does Humacyte Inc. stock have upside surprise potential - خودرو بانک
Signal Recap: Can Humacyte Inc deliver consistent EPS growthWeekly Loss Report & Reliable Volume Spike Alerts - خودرو بانک
Performance Recap: Will Humacyte Inc Equity Warrant outperform its industry peers2025 EndofYear Setup & Consistent Return Strategy Ideas - خودرو بانک
Market Outlook: Does Humacyte Inc have a sustainable dividendPortfolio Gains Report & Real-Time Stock Entry Alerts - خودرو بانک
Aug Action: Is Humacyte Inc a speculative investmentTrade Analysis Summary & AI Forecast for Swing Trade Picks - خودرو بانک
Block Trades: Is Humacyte Inc Equity Warrant a strong growth stockWeekly Profit Report & Growth Oriented Trading Recommendations - خودرو بانک
Risk Report: What analysts say about Humacyte Inc Equity Warrant stock2025 Biggest Moves & Risk Managed Investment Entry Signals - خودرو بانک
Humacyte's (HUMA) "Buy" Rating Reiterated at D. Boral Capital - MarketBeat
Quarterly Trades: Will EPIX outperform its industry peers2025 Growth vs Value & Daily Market Momentum Tracking - خودرو بانک
Risks Report: Whats the fair value of Humacyte Inc Equity Warrant stockTrade Volume Report & Consistent Return Investment Signals - خودرو بانک
MACD Signal: Whats the fair value of Humacyte Inc stockJuly 2025 Drop Watch & Risk Controlled Swing Trade Alerts - خودرو بانک
Movement Recap: Can Humacyte Inc sustain earnings growthEarnings Risk Summary & Low Drawdown Trading Techniques - خودرو بانک
Guidance Update: Can Humacyte Inc deliver consistent EPS growthTrade Analysis Summary & AI Forecasted Entry and Exit Points - خودرو بانک
Aug Drivers: Is La Z Boy Incorporated exposed to political risk2025 Retail Activity & Long-Term Growth Portfolio Plans - خودرو بانک
Value Recap: What analysts say about Humacyte Inc Equity Warrant stock2025 Performance Recap & Capital Efficiency Focused Ideas - خودرو بانک
Humacyte, Inc. Announces Publication of Outcomes for Patients with Hospital-Acquired Vascular Complications Treated with Symvess - MarketScreener
Aug EndMonth: What are the analyst revisions for Air T IncIs Humacyte Inc stock a good investment in YEAR - خودرو بانک
Humacyte reports positive outcomes for Symvess in vascular repairs - Investing.com India
EPS Watch: What are the analyst revisions for Air T IncIs Humacyte Inc stock a good investment in YEAR2025 Key Highlights & Accurate Intraday Trade Tips - خودرو بانک
Humacyte reports positive outcomes for Symvess in vascular repairs By Investing.com - Investing.com Nigeria
Humacyte, Inc. Announces Positive Outcomes for Symvess in Journal of Vascular Surgery Publication - Quiver Quantitative
Zero Infections, 100% Limb Salvage: Humacyte's Bioengineered Blood Vessel Shows Promise in Hospital Injuries - Stock Titan
Is Humacyte Inc Equity Warrant stock heavily shortedWeekly Market Summary & Real-Time Buy Zone Alerts - خودرو بانک
Humacyte Stock Hits Over 1-Month Highs On FDA Nod For Bioengineered Tissue In Treating Vascular Trauma, Retail Interest Soars - MSN
Humacyte Inc files for mixed shelf of up to $350 millionSEC filing - MarketScreener
Polar Asset Management Partners Inc. Buys Shares of 500,000 Humacyte, Inc. $HUMA - MarketBeat
294,392 Shares in Humacyte, Inc. $HUMA Bought by Nuveen LLC - MarketBeat
Can Humacyte Inc. deliver consistent EPS growthInsider Selling & AI Driven Stock Movement Reports - Lancaster City Council
Update Report: What are Humacyte Inc.’s technical support levelsJuly 2025 Trade Ideas & High Accuracy Investment Entry Signals - Lancaster City Council
Does Humacyte Inc. stock have upside surprise potentialInsider Buying & Risk Controlled Stock Alerts - beatles.ru
How do insiders feel about Humacyte Inc. Equity WarrantDollar Strength & AI Driven Stock Price Forecasts - 뉴스영
3,312,356 Shares in Humacyte, Inc. $HUMA Purchased by RA Capital Management L.P. - MarketBeat
What data driven models say about Humacyte Inc. Equity Warrant’s futureJuly 2025 Gainers & Precise Buy Zone Identification - Newser
Humacyte, Senseonics jump as Barclays issues new Overweight ratings - MSN
Is now the right time to enter Humacyte Inc. Equity Warrant2025 Major Catalysts & Proven Capital Preservation Methods - خودرو بانک
Is Humacyte Inc. backed by strong institutional buyingJuly 2025 Pullbacks & Capital Efficiency Focused Ideas - خودرو بانک
What technical models suggest about Humacyte Inc.’s comeback2025 Trading Recap & Scalable Portfolio Growth Methods - Newser
Can Humacyte Inc. Equity Warrant disrupt its industryJuly 2025 Pullbacks & Low Risk Entry Point Guides - خودرو بانک
Street Watch: What’s the outlook for Humacyte Inc.’s sectorJuly 2025 Movers & Free Growth Oriented Trading Recommendations - خودرو بانک
Humacyte Inc Stock (HUMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Humacyte Inc Stock (HUMA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dougan Brady W | Director |
Aug 18 '25 |
Sale |
1.83 |
549,360 |
1,005,329 |
1,691,685 |
| Dougan Brady W | Director |
Aug 20 '25 |
Sale |
1.58 |
591,685 |
934,862 |
0 |
| Niklason Laura E | President, CEO and Director |
Aug 19 '25 |
Sale |
1.63 |
1,100,000 |
1,793,000 |
591,685 |
| Niklason Laura E | President, CEO and Director |
Aug 18 '25 |
Sale |
1.83 |
549,360 |
1,005,329 |
1,691,685 |
| Niklason Laura E | President, CEO and Director |
Aug 20 '25 |
Sale |
1.58 |
591,685 |
934,862 |
0 |
0.25%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):